Peptide purity explained: what “99% by HPLC” means, what it doesn’t, and how to check it

Every research-peptide vendor quotes a purity figure, and most quote 98% or 99%. The number is real and useful, but it answers one narrow question, how much of what came off the column was the main peak, and it is routinely read as answering three others it does not: whether the main peak is the right molecule, how much of the powder is peptide, and whether the vial contains the stated mass. This guide explains how purity is measured, what the common impurities are, what the figure leaves out, and how to read a certificate so that the number means what you think it means. For laboratory research use only.

How purity is measured

Peptide purity is almost always determined by reversed-phase high-performance liquid chromatography (RP-HPLC). A small sample of the dissolved peptide is pumped through a column packed with hydrophobic particles; components separate by how strongly they stick to the packing, and a UV detector (usually at 214 or 220 nm, where the peptide bond absorbs) records a peak for each one as it elutes. Purity is the area of the main peak divided by the total area of all peaks, expressed as a percentage. “99% purity” means that 99% of the UV-absorbing material that eluted came out as one peak.

Method	Reversed-phase HPLC, UV detection at 214–220 nm
What it reports	Main peak area as % of total peak area
What it detects	Peptide-related impurities that absorb UV and separate from the main peak
What it misses	Water, salts and counter-ions (no UV absorbance); impurities that co-elute with the main peak; the identity of the main peak
Companion test	Mass spectrometry (identity: observed mass vs expected)
Related figure	Net peptide content (fraction of powder mass that is peptide)

What the impurities are

Synthetic peptides are built one residue at a time on a solid support, and every coupling step is slightly imperfect. The impurities that show up as minor HPLC peaks are therefore mostly near-relatives of the target:

• Deletion sequences: the peptide missing one residue because a coupling failed. For a 15-residue peptide there are 15 possible single deletions, each differing from the target by one amino acid.
• Truncated sequences: chains that stopped growing part-way and were capped.
• Incompletely deprotected peptide: a protecting group left on a side chain.
• Oxidised species: methionine or cysteine oxidised during synthesis, cleavage or storage; adds 16 Da per oxidation.
• Deamidated species: asparagine or glutamine converted to the acid; adds 1 Da and often resolves as a shoulder on the main peak.
• Diastereomers: a residue racemised during coupling, giving the same mass and often a very close retention time.
• Dimers and aggregates: particularly for cysteine-containing sequences.

Most of these have nearly the same mass and similar hydrophobicity to the target, which is why HPLC purification is the hard, expensive step in making a research peptide, and why the difference between a 95% and a 99% product is more than four percentage points of cost.

Three things “99%” does not tell you

1. It does not tell you the main peak is the right peptide

Purity is a ratio of peak areas. A vial of the wrong peptide, or of a deletion sequence that happens to dominate, can be “99% pure” by HPLC. Identity comes from mass spectrometry: the observed molecular mass must match the calculated mass for the sequence within the instrument’s tolerance. A certificate that reports purity without an observed mass has not confirmed what is in the vial. Our guide to reading a certificate of analysis shows where to find both numbers.

2. It does not tell you how much of the powder is peptide

Water, counter-ions and bulking agents do not absorb UV at 214 nm, so they are invisible to the purity measurement. A lyophilized peptide typically contains a few percent residual water and a counter-ion, usually trifluoroacetate (TFA) or acetate, bound to each basic residue. For a peptide rich in arginine and lysine, TFA can be 10–20% of the weighed mass. Net peptide content is the figure that accounts for this: the mass of peptide as a fraction of the mass of powder, usually determined by amino-acid analysis or UV absorbance against a standard. A “99% pure” peptide with 80% net peptide content contains 8 mg of peptide in a 10 mg vial. Few research vendors report net peptide content; when it is not reported, assume the label mass is gross powder mass. Our guide to lyophilized peptides covers where the extra mass comes from.

3. It does not tell you the vial contains the stated mass

Purity is measured on a sample, not on your vial. The label mass depends on the vendor’s dispensing. A lot certificate from an independent laboratory that reports the mass recovered from a vial, as well as purity and identity, closes this gap; a vendor’s own in-house figure, or a certificate with no lot number, does not.

What purity level a research use needs

There is no single answer, but the common guidance is: for crude screening and antibody work, 70–80% is often accepted; for cell-based assays, quantitative receptor work and anything where a minor impurity could be active, 95% and above; for structural work, reference standards and preclinical in-vivo models, 98% or higher. The relevant question is not just the percentage but what the impurities are: a 95% peptide whose 5% is deletion sequences with no activity is less of a problem than a 98% peptide whose 2% is an oxidised form that binds the same receptor.

Reading a purity figure on a certificate

• Look for the chromatogram, not just the number. A clean single peak with a flat baseline is the picture that “99%” should correspond to. Shoulders, a cluster of small peaks near the main one, or a broad main peak are worth asking about.
• Check the detection wavelength and method; 214–220 nm with a stated gradient is standard. A figure with no method is unverifiable.
• Match the observed mass from the MS panel against the calculated mass for the sequence. A difference of +16 or +32 suggests oxidation; +1 suggests deamidation; −18 suggests a dehydration or cyclisation.
• Confirm the lot number on the certificate matches the vial, and that the laboratory is named and independent of the vendor.
• If net peptide content is reported, use it, together with the label mass, when calculating concentration; the peptide calculator accepts the corrected mass.

How Quantum Peptides reports purity

Every lot we sell is tested by an independent US laboratory: identity by mass spectrometry and purity by RP-HPLC, to a minimum of 99% main-peak purity for peptides. The lot certificate, with the chromatogram and the observed mass, is linked on each product page. Where a product is a co-lyophilised blend, each component is reported separately. If a certificate does not show you what this guide says it should, ask; a supplier who cannot produce the chromatogram behind a purity number has not measured it.

Frequently asked questions

What does 99% peptide purity mean?

That 99% of the UV-absorbing material that eluted from the HPLC column came out as the main peak. It is a measure of how free the peptide is from closely related synthetic impurities, not of identity, net peptide content or vial mass.

Is purity the same as net peptide content?

No. Purity compares peptide-related peaks to each other. Net peptide content is the fraction of the powder’s mass that is peptide, after water and counter-ions are subtracted. A peptide can be 99% pure with 80% net peptide content.

What is the most common impurity in a synthetic peptide?

Deletion sequences, the target peptide missing one residue, followed by truncated chains, oxidised or deamidated forms, and incompletely deprotected peptide.

How do I confirm the peptide is the right one?

By mass spectrometry: the observed mass on the certificate should match the calculated mass for the sequence. Purity alone cannot confirm identity.

What is TFA and why does it matter?

Trifluoroacetic acid is used in peptide cleavage and HPLC purification, and the peptide is usually isolated as a TFA salt. The counter-ion adds to the weighed mass and is invisible to the purity measurement, which is why net peptide content is reported separately.

What purity should I use for cell-based research?

Generally 95% or higher, with 98–99% preferred where a minor impurity could be biologically active or where quantitative results matter.

References

1. Verbeken M, Wynendaele E, Lefebvre RA, et al. The influence of peptide impurity profiles on functional tissue–organ bath response. Analytical Biochemistry. 2012.
2. D’Hondt M, Bracke N, Taevernier L, et al. Related impurities in peptide medicines. Journal of Pharmaceutical and Biomedical Analysis. 2014.
3. Eggen I, Gregg B, Rode H, et al. Control strategies for synthetic therapeutic peptide APIs. Pharmaceutical Technology. 2014.

Quantum Peptides supplies lyophilised research peptides for in-vitro and preclinical laboratory research only. Products are not for human or veterinary use. This guide describes analytical practice and is not guidance on administration of any kind.